FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X recep...

Full description

Saved in:
Bibliographic Details
Main Authors SMITH, Nicholas D, GOVEK, Steven P, NAGASAWA, Johnny Y, LAI, Andiliy G, DOUGLAS, Karensa L
Format Patent
LanguageEnglish
Published 24.03.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
AbstractList Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Author SMITH, Nicholas D
DOUGLAS, Karensa L
NAGASAWA, Johnny Y
GOVEK, Steven P
LAI, Andiliy G
Author_xml – fullname: SMITH, Nicholas D
– fullname: GOVEK, Steven P
– fullname: NAGASAWA, Johnny Y
– fullname: LAI, Andiliy G
– fullname: DOUGLAS, Karensa L
BookMark eNrjYmDJy89L5WTQc3MM8nMN9vd0UYhQCHJ1dg0I8Q9ScHT39_MMDglWcPRzUQgNdg1WCPFwDXL1d-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRkYGFpam5qaOhsbEqQIAdGAodg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2022089575A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2022089575A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:05:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2022089575A13
Notes Application Number: US202117538394
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220324&DB=EPODOC&CC=US&NR=2022089575A1
ParticipantIDs epo_espacenet_US2022089575A1
PublicationCentury 2000
PublicationDate 20220324
PublicationDateYYYYMMDD 2022-03-24
PublicationDate_xml – month: 03
  year: 2022
  text: 20220324
  day: 24
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies Metacrine, Inc
RelatedCompanies_xml – name: Metacrine, Inc
Score 3.3839324
Snippet Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220324&DB=EPODOC&locale=&CC=US&NR=2022089575A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401ag3rRqr1Wyi4YYWWAo9NIbCIjURCA_DrYEtJCaGNhbj33egVHvqbXcnmX0k8_h2Z2cAHqiWcl5QBDlczUVaSJKoK5SLaqGmaK_zUbHJ9umOnJi-JmrSgc_tX5gmT-hPkxwRJYqjvFeNvl79X2JZTWzl-in7wKHlsx1NLKFFx3JdD5wK1nTCfM_yTME0J3EouMGGpo_ROTEQKx2gI63V8sDep_W_lNWuUbFP4dBHfmV1Bp287MGxua291oOjt_bJG5ut9K3P4dE2ApeF3swiCQmYyfzIC4jx4rmzMAqJ4VokRvVIIocFzLMv4N5mkemIOPH8b5_zONxdpXIJ3XJZ5ldAEEcWw2wxlLmO7kuapTxbUFlSCk0bcyplfRjs43S9n3wDJ3W3DqyS6QC61dd3fouWtsrumgP6BahZfJM
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNOJNUSOKuommtyotWyiHxpR2a6vQkj4MN9IubWJiCpEa_77TAsqJ22YnmX0k8_h25wHwQPsx5xlFkMOVVKSZJIlql3JRyZQY7XXay9bVPt2eHdHXqTKtwec2F6aqE_pTFUdEieIo70Wlr5f_j1hmFVu5eko-cGrxbIWaKWzQsVz2A6eCOdTYxDM9QzAMLQoE11_T1AE6JzpipQN0stWy3wF7H5Z5Kctdo2KdwOEE-eXFKdTSvAkNY9t7rQlH482XNw430rc6g0dL910WeI5JpsRnBpuEnk_0F891gjAgumuSCNUjCW3mM886h3uLhYYt4sKzv3POomB3l90LqOeLPL0Egjgy6yTzjsxVdF_iJObJnMpSN-v3B5xKSQva-zhd7SffQcMOx6PZyHHfruG4JJVBVjJtQ734-k5v0OoWyW11Wb-nv3-D
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FARNESOID+X+RECEPTOR+AGONISTS+AND+USES+THEREOF&rft.inventor=SMITH%2C+Nicholas+D&rft.inventor=GOVEK%2C+Steven+P&rft.inventor=NAGASAWA%2C+Johnny+Y&rft.inventor=LAI%2C+Andiliy+G&rft.inventor=DOUGLAS%2C+Karensa+L&rft.date=2022-03-24&rft.externalDBID=A1&rft.externalDocID=US2022089575A1